J B Chemicals and Pharmaceuticals Share Price

NSE: JBCHEPHARM

₹ 2,408.90

-₹97.10 (-3.87%)

Last updated 16 Jul, 2026, 15:59 IST

J B Chemicals and Pharmaceuticals Share Price Today

As of 27 Jul 2026, J B Chemicals and Pharmaceuticals share price is ₹2,408.90. The stock opened at ₹2,506.00, compared to its previous close of ₹2,506.00. During today's trading session, J B Chemicals and Pharmaceuticals share price moved in the range of ₹2,380.00 to ₹2,525.50, with an average price of ₹2,452.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,638.50 and a high of ₹2,525.50.

₹2,380.00

3.87% down today

₹2,525.50

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 7.32% YoY

Latest Earning

Net Profit TrendUp by 7.56% YoY

Latest Earning

Revenue TrendUp by 6.36% YoY

Stock Performance

OutperformingBeat Nifty by 10.91 % in last 1 month

Shareholding Pattern

PromoterPromoter increased stake by 0.04%

Shareholding Pattern

DIIDII decreased stake by 31.65%

Shareholding Pattern

FIIFII increased stake by 12.19%

J B Chemicals and Pharmaceuticals Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹7,05,181+₹2,05,181 (+41.04%)

3 Year

₹9,63,136+₹4,63,136 (+92.63%)

5 Year

₹13,28,535+₹8,28,535 (+165.71%)

₹2,004.80₹3,007.20

Circuit Low

Circuit High

₹1,638.50₹2,525.50

52-Week Low

52-Week High

Circuit

₹2,004.80

₹3,007.20

52-week

₹1,638.50

₹2,525.50

Mkt Cap Cr

38,730.80

P/E

46.69

P/B

7.96

ROE

18.69%

D/E

0.00

ROCE

24.94%

Div. Yield

1.07%

EPS(TTM)

42.91

Turnover

0.91

EV/EBITDA

28.92

Net Margin

17.33%

Op. Margin

27.87%

ROA

16.91%

Quick Ratio

3.70

Curr. Ratio

2.22

Mkt Cap Cr

38,730.80

P/E

46.69

P/B

7.96

ROE

18.69%

D/E

0.00

ROCE

24.94%

Div. Yield

1.07%

EPS(TTM)

42.91

Turnover

0.91

EV/EBITDA

28.92

Net Margin

17.33%

Op. Margin

27.87%

ROA

16.91%

Quick Ratio

3.70

Curr. Ratio

2.22

Based on fundamentals, this stock's

Performance

Excellent

J B Chemicals & outperforming all market indices

Valuation

Overvalued

J B Chemicals & appears overvalued compared to its peers

Earnings

Neutral

J B Chemicals & earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,65,711.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,92,376.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,88,655.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,13,979.00	33.96	3.31	11.27%	0.00	14.95%	423.36	0.92%	0.45	43.52
Zydus Lifesciences	1,10,613.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,08,339.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,03,472.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	96,204.70	30.22	2.53	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,949.80	25.39	2.35	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	86,564.20	79.36	16.33	16.77%	0.40	16.14%	97.21	0.12%	0.67	13.72

J B Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹4,147.79	₹3,917.99	₹3,484.18	₹3,149.28
Other Income	₹60.15	₹38.32	₹37.27	₹9.94
Total Revenue	₹4,207.94	₹3,956.31	₹3,521.45	₹3,159.22
Total Expenses	₹3,228.42	₹3,068.92	₹2,769.94	₹2,603.99
Profit Before Tax	₹952.34	₹887.39	₹751.51	₹555.23
Tax	₹242.86	₹227.81	₹198.88	₹145.23
Profit After Tax	₹709.47	₹659.58	₹552.63	₹410.01
EPS - Basic	₹45.16	₹42.45	₹35.66	₹53.00
EPS - Diluted	₹44.45	₹41.56	₹34.85	₹52.34

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹952.34	₹887.39	₹751.51	₹555.23
Income before WC changes	₹1,191.46	₹1,095.95	₹938.73	₹751.01
Change in Assets	-₹211.03	-₹76.24	-₹143.63	-₹62.27
Change in Liabilities	-₹20.27	₹83.42	₹138.00	₹32.35
Change in WC	-₹231.30	₹7.17	-₹5.64	-₹29.92
Cash flow from Operations	₹703.92	₹902.45	₹800.61	₹625.61
Cash flow from Investing	-₹585.88	-₹295.90	-₹403.83	-₹961.79
Cash flow from Financing	-₹123.10	-₹579.67	-₹385.49	₹356.54
Total Cash Flow	-₹5.05	₹26.88	₹11.30	₹20.36
Cash (Start of the year)	₹115.09	₹88.22	₹76.93	₹56.54
Cash (End of the year)	₹110.18	₹115.09	₹88.22	₹76.93

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹2,059.27	₹2,351.04	₹2,140.78	₹2,025.84
Current Assets	₹2,909.37	₹1,922.74	₹1,853.35	₹1,528.03
Total Assets	₹4,968.65	₹4,273.78	₹3,994.13	₹3,553.87
Current Liabilities	₹591.16	₹632.34	₹868.23	₹554.45
Net Current Asset	₹2,318.21	₹1,290.40	₹985.12	₹973.58
Non-Current Liabilities	₹218.26	₹208.13	₹202.57	₹519.07
Equity Capital	₹4,159.22	₹3,433.32	₹2,923.33	₹2,480.35
Total Equity & Liabilities	₹4,968.65	₹4,273.78	₹3,994.13	₹3,553.87

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹3,889.89	₹3,722.92	₹3,298.64	₹2,884.16
Other Income	₹55.28	₹34.74	₹34.67	₹8.65
Total Revenue	₹3,945.17	₹3,757.66	₹3,333.32	₹2,892.81
Total Expenses	₹3,015.26	₹2,880.56	₹2,594.98	₹2,365.77
Profit Before Tax	₹902.73	₹877.11	₹738.34	₹527.04
Tax	₹228.63	₹224.56	₹194.98	₹138.15
Profit After Tax	₹674.10	₹652.54	₹543.36	₹388.89
EPS - Basic	₹42.91	₹42.00	₹35.07	₹50.29
EPS - Diluted	₹42.23	₹41.16	₹34.30	₹49.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹902.73	₹877.11	₹738.34	₹527.04
Income before WC changes	₹1,111.93	₹1,071.17	₹925.60	₹729.85
Change in Assets	-₹204.76	-₹76.58	-₹140.93	-₹56.66
Change in Liabilities	-₹16.19	₹82.28	₹132.29	₹44.04
Change in WC	-₹220.94	₹5.70	-₹8.64	-₹12.62
Cash flow from Operations	₹644.89	₹884.03	₹789.03	₹628.64
Cash flow from Investing	-₹587.21	-₹289.93	-₹412.45	-₹955.88
Cash flow from Financing	-₹107.68	-₹574.27	-₹374.08	₹343.41
Total Cash Flow	-₹50.00	₹19.84	₹2.50	₹16.17
Cash (Start of the year)	₹76.21	₹56.37	₹53.88	₹37.69
Cash (End of the year)	₹26.36	₹76.21	₹56.37	₹53.88

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹2,106.18	₹2,399.24	₹2,198.24	₹2,071.85
Current Assets	₹2,717.32	₹1,778.65	₹1,715.40	₹1,398.30
Total Assets	₹4,823.50	₹4,177.90	₹3,913.64	₹3,470.15
Current Liabilities	₹560.91	₹584.44	₹821.06	₹508.03
Net Current Asset	₹2,156.41	₹1,194.22	₹894.34	₹890.27
Non-Current Liabilities	₹224.88	₹216.26	₹206.32	₹519.64
Equity Capital	₹4,037.71	₹3,377.19	₹2,886.26	₹2,442.48
Total Equity & Liabilities	₹4,823.50	₹4,177.90	₹3,913.64	₹3,470.15

* All values are in INR Crore

Qty

Bid

2703

2408.9

Ask

Qty

Bid Total: 2703

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

60.98

Neutral

ATR (14)

59.76

Neutral

STOCH(9,6)

33.41

Neutral

STOCH RSI (14)

Bullish

ADX(9)

48.89

Bearish

UO(9)

59.33

Neutral

ROC(12)

4.92

Bullish

WillR(14)

-40.32

Neutral

Period

Simple value

Exponential vaue

2459.6

2448.89

10D

2435.49

2423.45

20D

2344.27

2366.34

50D

2241.45

2259.72

100D

2142.03

2158.39

About J B Chemicals and Pharmaceuticals

ISIN

INE572A01036

Sector Market Cap

₹ 38,730.8 Cr

J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.

J B Chemicals and Pharmaceuticals Financial Highlights

Revenue: J B Chemicals and Pharmaceuticals reported revenue of ₹4,207.94 crore in FY26 vs ₹3,956.31 crore in FY25. It showed an increase of 6.36% on a yearly basis.
Operating Profit: J B Chemicals and Pharmaceuticals reported an operating profit of ₹952.33 crore in FY26 vs ₹887.39 crore in FY25. It showed an increase of 7.32% on a year-on-year basis.
Net Profit: J B Chemicals and Pharmaceuticals reported a net profit of ₹709.47 crore in FY26 vs ₹659.58 crore in FY25. It showed an increase of 7.56% on a yearly basis.

J B Chemicals and Pharmaceuticals Quarterly Result Highlights

J B Chemicals and Pharmaceuticals reported revenue of ₹916.21 crore in Mar 2026, compared with ₹1,083.00 crore in Dec 2025, representing a decrease of 15.40% on a quarter-on-quarter (QoQ) basis.
J B Chemicals and Pharmaceuticals reported an operating profit of ₹134.69 crore in Mar 2026, compared with ₹266.87 crore in Dec 2025, representing a decrease of 49.53% on a quarter-on-quarter (QoQ) basis.
J B Chemicals and Pharmaceuticals reported a profit of ₹101.37 crore in Mar 2026, compared with ₹197.89 crore in Dec 2025, reflecting a decrease of 48.77% on a QoQ basis.
The earnings per share (EPS) of J B Chemicals and Pharmaceuticals stood at ₹45.16 during Mar 2026.